Gregory Wiener1, Hunter B Moore2, Ernest E Moore3, Eduardo Gonzalez1, Scott Diamond4, Shu Zhu4, Angelo D'Alessandro1, Anirban Banerjee1. 1. Department of Surgery, University of Colorado Denver, Aurora, Colorado. 2. Department of Surgery, University of Colorado Denver, Aurora, Colorado. Electronic address: hunter.moore@ucdenver.edu. 3. Department of Surgery, University of Colorado Denver, Aurora, Colorado; Department of Surgery, Denver Health Medical Center, Denver, Colorado. 4. Institute for Medicine & Engineering, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: Metabolites are underappreciated for their effect on coagulation. Taurocholic acid (TUCA), a bile acid, has been shown to regulate cellular activity and promote fibrin sealant degradation. We hypothesize that TUCA impairs whole blood clot formation and promotes fibrinolysis. METHODS: TUCA was exogenously added to whole blood obtained from volunteers. A titration from 250 μM-750 μM was used due to biologic relevance. Whole blood mixtures were assayed using thrombelastography for clot strength (maximum amplitude [MA]) and fibrinolysis (LY30) quantification. Tranexamic acid was used to block plasmin-mediated fibrinolysis. Platelet microfluidics were performed. A proteomic analysis was completed on citrated plasma obtained from a shock and resuscitation rat model. RESULTS: Fibrinolysis increased when 750-μM TUCA was added to whole blood (median LY30 0.08-5.7, P = 0.010) and clot strength decreased (median MA of 53.3-43.8, P = 0.010). The addition of tranexamic acid, to a 750-μM TUCA titration, partially reversed the induced fibrinolysis (LY30: without 7.7 versus with 2.7) and the decrease in clot strength (MA: without 48.2 versus with 53.2), but did not reverse the effects to whole blood levels. Platelet function reduced by 50% in the presence of 100-μM TUCA. Rats had a median 52-fold increase in TUCA, after a shock state that stayed elevated after resuscitation. CONCLUSIONS: TUCA reduces clot strength and promotes fibrinolysis. The clot strength reduction is attributable to platelet inhibition. This metabolic effect on coagulation warrants further investigation, as localized areas of the body, with high levels of bile acid, may be at risk for postoperative bleeding.
BACKGROUND: Metabolites are underappreciated for their effect on coagulation. Taurocholic acid (TUCA), a bile acid, has been shown to regulate cellular activity and promote fibrin sealant degradation. We hypothesize that TUCA impairs whole blood clot formation and promotes fibrinolysis. METHODS:TUCA was exogenously added to whole blood obtained from volunteers. A titration from 250 μM-750 μM was used due to biologic relevance. Whole blood mixtures were assayed using thrombelastography for clot strength (maximum amplitude [MA]) and fibrinolysis (LY30) quantification. Tranexamic acid was used to block plasmin-mediated fibrinolysis. Platelet microfluidics were performed. A proteomic analysis was completed on citrated plasma obtained from a shock and resuscitation rat model. RESULTS: Fibrinolysis increased when 750-μM TUCA was added to whole blood (median LY30 0.08-5.7, P = 0.010) and clot strength decreased (median MA of 53.3-43.8, P = 0.010). The addition of tranexamic acid, to a 750-μM TUCA titration, partially reversed the induced fibrinolysis (LY30: without 7.7 versus with 2.7) and the decrease in clot strength (MA: without 48.2 versus with 53.2), but did not reverse the effects to whole blood levels. Platelet function reduced by 50% in the presence of 100-μM TUCA. Rats had a median 52-fold increase in TUCA, after a shock state that stayed elevated after resuscitation. CONCLUSIONS:TUCA reduces clot strength and promotes fibrinolysis. The clot strength reduction is attributable to platelet inhibition. This metabolic effect on coagulation warrants further investigation, as localized areas of the body, with high levels of bile acid, may be at risk for postoperative bleeding.
Authors: Ines Burkard; Arnold von Eckardstein; Katharina M Rentsch Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2005-09-22 Impact factor: 3.205
Authors: Fu Si-Yuan; Lau Wan Yee; Yang Yuan; Yuan Sheng-Xian; Wang Zheng-Guang; Huang Gang; Wu Meng-Chao; Zhou Wei-Ping Journal: Int J Surg Date: 2014-06-05 Impact factor: 6.071
Authors: Elizabeth A Boonstra; Jelle Adelmeijer; Henkjan J Verkade; Marieke T de Boer; Robert J Porte; Ton Lisman Journal: Ann Surg Date: 2012-08 Impact factor: 12.969
Authors: Peter P Rainer; Uwe Primessnig; Sandra Harenkamp; Bernhard Doleschal; Markus Wallner; Guenter Fauler; Tatjana Stojakovic; Rolf Wachter; Ameli Yates; Klaus Groschner; Michael Trauner; Burkert M Pieske; Dirk von Lewinski Journal: Heart Date: 2013-07-26 Impact factor: 7.365
Authors: Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Angela Sauaia; Anirban Banerjee; Christopher C Silliman Journal: Transfusion Date: 2016-04 Impact factor: 3.157
Authors: Nathan Clendenen; Geoffrey R Nunns; Ernest E Moore; Eduardo Gonzalez; Michael Chapman; Julie A Reisz; Erik Peltz; Miguel Fragoso; Travis Nemkov; Matthew J Wither; Angela Sauaia; Christopher C Silliman; Kirk Hansen; Anirban Banerjee; Angelo D'Alessandro; Hunter B Moore Journal: Blood Transfus Date: 2018-12-13 Impact factor: 3.443
Authors: Hunter B Moore; Angelo D'Alessandro; Ernest E Moore; Matthew Wither; Peter J Lawson; Benjamin R Huebner; Kirk Hansen; Rashikh Choudhury; Trevor L Nydam Journal: Blood Transfus Date: 2019-02-04 Impact factor: 3.443
Authors: Hunter B Moore; Ernest E Moore; Ioannis N Liras; Eduardo Gonzalez; John A Harvin; John B Holcomb; Angela Sauaia; Bryan A Cotton Journal: J Am Coll Surg Date: 2016-01-22 Impact factor: 6.113
Authors: Julie A Reisz; Anne L Slaughter; Rachel Culp-Hill; Ernest E Moore; Christopher C Silliman; Miguel Fragoso; Erik D Peltz; Kirk C Hansen; Anirban Banerjee; Angelo D'Alessandro Journal: Blood Adv Date: 2017-07-14
Authors: Nathan Clendenen; Geoffrey R Nunns; Ernest E Moore; Julie A Reisz; Eduardo Gonzalez; Erik Peltz; Christopher C Silliman; Miguel Fragoso; Travis Nemkov; Matthew J Wither; Kirk Hansen; Anirban Banerjee; Hunter B Moore; Angelo DʼAlessandro Journal: J Trauma Acute Care Surg Date: 2017-10 Impact factor: 3.313
Authors: H B Moore; E E Moore; M P Chapman; E Gonzalez; A L Slaughter; A P Morton; A D'Alessandro; K C Hansen; A Sauaia; A Banerjee; C C Silliman Journal: J Thromb Haemost Date: 2015-09-22 Impact factor: 5.824
Authors: Alexander T Fields; Zachary A Matthay; Brenda Nunez-Garcia; Ellicott C Matthay; Roland J Bainton; Rachael A Callcut; Lucy Z Kornblith Journal: Shock Date: 2021-02-01 Impact factor: 3.454